EUVIMEDEUVIMED entdecken
LeserbriefKohortenstudie

Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study

Katelyn Sarkovics, Joanna A Kolodney, Michael S Kolodney

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae172 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Katelyn Sarkovics und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, West Virginia University, Morgantown, WV, USA. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Immune Checkpoint Inhibitors, B7-H1 Antigen, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We provide a comparison of the bullous pemphigoid (BP)-free survival probability in patients starting PD-1/PD-L1 inhibitors and DPP-4 inhibitors that has not been previously demonstrated in other studies. A propensity-matched retrospective cohort study performed with TriNetX participants revealed a significantly increased risk of BP in patients starting PD-1/PD-L1 inhibitors, especially in male patients and those aged > 65 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousImmune Checkpoint InhibitorsB7-H1 AntigenProgrammed Cell Death 1 ReceptorHumansRetrospective StudiesMaleFemaleAgedPropensity ScoreMiddle AgedAged, 80 and over

Substanzen

Immune Checkpoint InhibitorsB7-H1 AntigenProgrammed Cell Death 1 ReceptorCD274 protein, humanPDCD1 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, West Virginia University, Morgantown, WV, USA.
  • Department of Medicine, Division of Hematology-Oncology, West Virginia University, Morgantown, WV, USA.

Zitieren

APA

Sarkovics, K., Kolodney, J. A., & Kolodney, M. S. (2024). Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae172

Vancouver

Sarkovics K, Kolodney JA, Kolodney MS. Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae172

BibTeX
@article{Sarkovics2024,
  author = {Sarkovics, Katelyn and Kolodney, Joanna A and Kolodney, Michael S},
  title = {Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae172}
}
Kostenlos starten →